Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2014 Oct 14;111(8):1677-8.
doi: 10.1038/bjc.2014.129. Epub 2014 Mar 18.

Reply: 'Comments on Stromal disrupting effects of nab-paclitaxel in pancreatic cancer'

R Alvarez  1 , M Musteanu  2 , E Garcia-Garcia  2 , P P Lopez-Casas  2 , D Megias  2 , C Guerra  2 , M Muñoz  2 , Y Quijano  1 , A Cubillo  1 , J Rodriguez-Pascual  1 , C Plaza  1 , E de Vicente  1 , S Prados  1 , S Tabernero  1 , M Barbacid  2 , F Lopez-Rios  1 , M Hidalgo  3
Affiliations
Comment

Reply: 'Comments on Stromal disrupting effects of nab-paclitaxel in pancreatic cancer'

R Alvarez et al. Br J Cancer. .
No abstract available

PubMed Disclaimer

Comment on

  • Stromal disrupting effects of nab-paclitaxel in pancreatic cancer.
    Alvarez R, Musteanu M, Garcia-Garcia E, Lopez-Casas PP, Megias D, Guerra C, Muñoz M, Quijano Y, Cubillo A, Rodriguez-Pascual J, Plaza C, de Vicente E, Prados S, Tabernero S, Barbacid M, Lopez-Rios F, Hidalgo M. Alvarez R, et al. Br J Cancer. 2013 Aug 20;109(4):926-33. doi: 10.1038/bjc.2013.415. Epub 2013 Aug 1. Br J Cancer. 2013. PMID: 23907428 Free PMC article.
  • Stellate cells, a point of light in the dark night of pancreatic cancer.
    Ramírez N, Viúdez A, Hernández-García I, Guerrero D, Gómez-Dorronsoro M, Herrera FJ, Vila J, Beloki L, Ciaúrriz M, Mansilla C, Vera R. Ramírez N, et al. Br J Cancer. 2014 Oct 14;111(8):1676-7. doi: 10.1038/bjc.2014.59. Epub 2014 Mar 18. Br J Cancer. 2014. PMID: 24642614 Free PMC article. No abstract available.
  • Neoadjuvant chemotherapy in pancreatic cancer: innovative, but still difficult.
    Boeck S, Haas M, Ormanns S, Kruger S, Siveke JT, Heinemann V. Boeck S, et al. Br J Cancer. 2014 Oct 14;111(8):1675-6. doi: 10.1038/bjc.2014.60. Epub 2014 Mar 18. Br J Cancer. 2014. PMID: 24642615 Free PMC article. No abstract available.

References

    1. Alvarez R, Musteanu M, Garcia-Garcia E, Lopez-Casas PP, Megias D, Guerra C, Muñoz M, Quijano Y, Cubillo A, Rodriguez-Pascual J, Plaza C, de Vicente E, Prados S, Tabernero S, Barbacid M, Lopez-Rios F, Hidalgo M. Stromal disrupting effects of nab-paclitaxel in pancreatic cancer. Br J Cancer. 2013;109:926–933. - PMC - PubMed
    1. Boeck S, Haas M, Ormanns S, Kruger S, Siveke JT, Heinemann V.2014Neoadjuvant chemotherapy in pancreatic cancer: innovative, but still difficult Br J Cancere-pub ahead of print 18 March 2014 doi: 10.1038/bjc.2014.60 - DOI - PMC - PubMed
    1. Frese KK, Neesse A, Cook N, Bapiro TE, Lolkema MP, Jodrell DI, Tuveson DA. nab-Paclitaxel potentiates gemcitabine activity by reducing cytidine deaminase levels in a mouse model of pancreatic cancer. Cancer Discov. 2012;2:260–269. - PMC - PubMed
    1. Ramírez N, Viúdez A, Hernández-García I, Guerrero D, Gómez-Dorronsoro M, Herrera FJ, Vila J, Beloki L, Ciaúrriz M, Mansilla C, Vera R.2014Stellate cells, a point of light in the dark night of pancreatic cancer Br J Cancere-pub ahead of print 18 March 2014 doi: 10.1038/bjc.2014.59 - DOI - PMC - PubMed
    1. Von Hoff DD, Ervin T, Arena FP, Chiorean EG, Infante J, Moore M, Seay T, Tjulandin SA, Ma WW, Saleh MN, Harris M, Reni M, Dowden S, Laheru D, Bahary N, Ramanathan RK, Tabernero J, Hidalgo M, Goldstein D, Van Cutsem E, Wei X, Iglesias J, Renschler MF. Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine. N Engl J Med. 2013;369 (18:1691–1703. - PMC - PubMed